Central Trust Company’s Biohaven BHVN Stock Holding History

Central Trust Company’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-102	Closed	-$15K	–	1253
2022 Q3	$15K	Buy	+102	New	+$740	﹤0.01%	971

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Central Trust Company's BHVN Position: Q4 2022 in Review

Central Trust Company sold out of Biohaven (BHVN) in Q4 2022, closing a stake of 102 shares — an estimated $15K sold.

Central Trust Company first reported a position in BHVN in Q3 2022 and held it in 1 quarter. The position peaked at $15K in Q3 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

Central Trust Company reported no remaining Biohaven position as of Q4 2022 after selling out during the quarter.
Central Trust Company sold 102 Biohaven shares in Q4 2022, an estimated $15K.
Central Trust Company first reported a position in Biohaven in Q3 2022 and held it in 1 quarter.
Central Trust Company's Biohaven position peaked at $15K in Q3 2022.
176 funds tracked by Wall St. Rank held Biohaven as of Q4 2022.

Based on Central Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.